Stock listing

Stuttgart:1AE argenx SE Aktie

German listing (Stuttgart) of argenx SE · home listing Euronext:ARGX

Follow argenx SE into a list and get an email when it puts out news.

Share price · SWB:1AE

€792.80 EUR +11.00 (+1.4%)

Close on Oct 27, 2026

Day range
€773.60 – €792.80 EUROct 27, 2026
Market cap
€14.70B EURAt the close on Oct 27, 2026 · price × 18.54M shares outstanding
argenx SE logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
Euronext:ARGX · Home€807.20 EUR+2.80 (+0.3%)94,245€805.20€820.60€797.40€804.40Close on Oct 30, 2026
NASDAQ:ARGX$882.48 USD+8.775 (+1.0%)290,153$864.81$882.60$859.32$873.71Close on Oct 27, 2026
Frankfurt:1AE€797.00 EUR+21.40 (+2.8%)—€797.00€797.00€797.00€775.60Close on Oct 30, 2026
B3:A1RG34162.13 BRL0.00 (0.0%)—162.13162.13162.13162.13Close on Oct 21, 2026
Stuttgart:1AE€792.80 EUR+11.00 (+1.4%)—€778.60€792.80€773.60€781.80Close on Oct 27, 2026
Frankfurt:1AEA€805.00 EUR+35.00 (+4.5%)—€760.00€805.00€760.00€770.00Close on Oct 30, 2026
Stuttgart:1AEA€790.00 EUR——€775.00€790.00€745.00—Close on Oct 21, 2026
Ticker
Stuttgart:1AE
Asset type
Stock
Exchange
Stuttgart
Currency
EUR

What changed lately

Calls

Replays

  • Argenx (Euronext:ARGX) Q3 2026 Earnings Call

    Thu, Oct 22, 2026 · 8:30 AM ET

    Watch Transcript

  • Argenx (Euronext:ARGX) Q2 2026 Earnings Call

    Thu, Jul 23, 2026 · 9:30 AM ET

    Watch Transcript

  • Argenx (Euronext:ARGX) Q1 2026 Earnings Call

    Thu, May 07, 2026 · 8:30 AM ET

    Watch Transcript

Latest news

Argenx to Report Third Quarter 2026 Financial Results and Business Update on October 22, 2026

Oct 15, 2026

Argenx argenx Announces Positive Topline Results from Phase 2 Study of FB102 in Celiac Disease

Oct 8, 2026

Argenx announces results of Extraordinary General Meeting of Shareholders and appointment of Thomas M. Brakel and Khurem Farooq as Non-Executive Directors

Sep 17, 2026

Argenx argenx to Present at Upcoming Investor Conferences

Sep 1, 2026

Argenx Completes Acquisition of Forte Biosciences, Inc.

Aug 27, 2026

Argenx argenx Announces Positive Topline Results from Phase 3 ALKIVIA Trial of Efgartigimod in Autoimmune Myositis

Aug 17, 2026

Argenx Announces Commencement of Tender Offer to Acquire Forte Biosciences, Inc.

Aug 6, 2026

Argenx announces Extraordinary General Meeting of Shareholders on September 17, 2026

Aug 3, 2026

argenx to Acquire Forte Biosciences, Inc., Adding First-in-Class Anti-CD122 Antibody, FB102, to Its Immunology Pipeline

Jul 27, 2026

Argenx Reports Half Year 2026 Financial Results and Provides Second Quarter Business Update

Jul 23, 2026

All argenx SE news

Decks

argenx SE on 6ix

News releases
36 in the last 12 months · 58 in all · newest Oct 15, 2026 · oldest 2025
Calls
25 calls with a replay · 25 with a transcript · latest Oct 22, 2026
Decks
72 decks · latest Oct 22, 2026

Where argenx SE is listed

ListingExchangeCountryCurrency
Euronext:ARGX · Home listingEuronextBelgiumEUR
NASDAQ:ARGXNASDAQUnited StatesUSD
gettex:1AEgettexGermanyEUR
LSIN:0QW0LSINUnited KingdomEUR
OTC:ARGNFOTCUnited StatesUSD
Tradegate:1AETradegateGermanyEUR
Aquis:ARGXBAquisUnited KingdomEUR
Xetra:1AEXetraGermanyEUR
LS Exchange:A11602LS ExchangeGermanyEUR
Dusseldorf:1AEDusseldorfGermanyEUR
Lang & Schwarz:A11602Lang & SchwarzGermanyEUR
gettex:1AEAgettexGermanyEUR
Frankfurt:1AEFrankfurtGermanyEUR
VIE:ARGXViennaAustriaEUR
B3:A1RG34B3BrazilBRL
BMV:ARGXNBMVMexicoMXN
BOATS:ARGXBOATSUnited StatesUSD
Hamburg:1AEHamburgGermanyEUR
Munich:1AEMunichGermanyEUR
Lang & Schwarz:A2H9WDLang & SchwarzGermanyEUR
Turquoise:ARGXBTurquoiseUnited KingdomEUR
Aquis:ARGXBAquisUnited KingdomEUR
Stuttgart:1AE · This pageStuttgartGermanyEUR
Dusseldorf:1AEADusseldorfGermanyEUR
Frankfurt:1AEAFrankfurtGermanyEUR
Hamburg:1AEAHamburgGermanyEUR
Hanover:1AEAHanoverGermanyEUR
LS Exchange:A2H9WDLS ExchangeGermanyEUR
Munich:1AEAMunichGermanyEUR
Stuttgart:1AEAStuttgartGermanyEUR

Log in to ask 6ix AI your own questions about argenx SE.